Search

Katherine C Jancsics

from Wilmington, MA
Age ~46
Get Report
Also known as:
Katherine Christine Jancsics, Katherine C Ambrosio, Kathy Jancsics, Kate Ambrosio, Jancsics Katherine
Phone and address:
32 Hopkins St, Wilmington, MA 01887
(978) 658-6447
Related to:
Etta M JancsicsDenise Sowers, 51Penny M Lazaron, 47Mathew JancsicsTracy Lazaron, 58
Connected to:
Steven H Jancsy, 74Agnieszka Janczak, 51Caroline A Janczak, 63Chester F Janczak, 60Jodie M Janczak, 67Jon M Janczak, 50Krzysztof Janczak, 48Maria K Janczak, 29Mary B Janczak, 73Mason A Janczak, 43

Katherine Jancsics Phones & Addresses

  • 32 Hopkins St, Wilmington, MA 01887 (978) 658-6447
  • Reading, MA
  • 201 Main St, Woburn, MA 01801
  • Waltham, MA
  • Westborough, MA
  • Arlington, VA
  • Washington, DC
  • Northampton, MA
  • 32 Hopkins St, Wilmington, MA 01887

Work

Company: Emd millipore Mar 2012 Position: Technical services specialist

Education

School / High School: George Washington University- Washington, DC 1999 Specialities: MS in Organic Chemistry

Resumes

Resumes

Katherine Jancsics Photo 1

Katherine Jancsics Wilmington, MA

View page
Work:
EMD Millipore

Mar 2012 to 2000
Technical Services Specialist
Genzyme
Waltham, MA
Feb 2004 to Feb 2012
Principle Research Associate
Pharm-Eco, A Johnson-Matthey Company
Devens, MA
Apr 2002 to Feb 2004
Chemist
Education:
George Washington University
Washington, DC
1999 to 2001
MS in Organic Chemistry
Smith College
Northampton, MA
1995 to 1999
BA in Chemistry

Publications

Us Patents

Glucosylceramide Synthase Inhibitors

View page
US Patent:
20200048266, Feb 13, 2020
Filed:
Aug 15, 2019
Appl. No.:
16/542166
Inventors:
- Cambridge MA, US
Cassandra CELATKA - Hull MA, US
Seng CHENG - Natick MA, US
Mary A. CROMWELL - Groton MA, US
Andrew GOOD - Wallingford CT, US
Bradford HIRTH - Framingham MA, US
Katherine JANCSICS - Wilmington MA, US
John P. LEONARD - Manchester NH, US
Lingyun LI - Waltham MA, US
James LILLIE - Wellesley MA, US
Hanlan LIU - Lexington MA, US
Elina MAKINO - Winchester MA, US
John MARSHALL - Hopedale MA, US
Paul MASON - Natick MA, US
Markus METZ - Waltham MA, US
Fazeela MORSHED - Waltham MA, US
Thomas O'SHEA - Wellesley MA, US
Ronald SCHEULE - Hopkinton MA, US
Renato SKERLJ - West Newton MA, US
Bing WANG - Newton MA, US
Yibin XIANG - Dracut MA, US
Zhong ZHAO - Wayland MA, US
International Classification:
C07D 487/08
A61K 31/439
A61K 31/454
A61K 38/47
C07D 453/02
C07D 453/00
A61K 31/46
A61K 31/506
A61K 31/551
C07D 455/02
Abstract:
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.

Glucosylceramide Synthase Inhibitors

View page
US Patent:
20180065957, Mar 8, 2018
Filed:
Apr 18, 2017
Appl. No.:
15/490385
Inventors:
- Cambrdige MA, US
Cassandra CELATKA - Hull MA, US
Seng H. CHENG - Natick MA, US
Bradford Hirth - Littleton MA, US
Andrew GOOD - Wallingford CT, US
Katherine JANCSICS - Wilmington MA, US
John MARSHALL - Charlestown MA, US
Markus Metz - Encinitas CA, US
Ronald K. SCHEULE - Hopkinton MA, US
Renato SKERLJ - W. Newton MA, US
Yibin XIANG - Dracut MA, US
Zhong ZHAO - Wayland MA, US
John LEONARD - Manchester NH, US
Thomas NATOLI - Revere MA, US
Elina MAKINO - Winchester MA, US
Herve HUSSON - Boston MA, US
Oxana BESKROVNAYA - Southborough MA, US
Assignee:
Genzyme Corporation - Cambrdige MA
International Classification:
C07D 453/02
C07D 471/08
A61K 45/06
A61K 31/551
A61K 31/55
A61K 31/496
A61K 31/497
A61K 31/506
A61K 31/5377
A61K 31/439
Abstract:
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.

Glucosylceramide Synthase Inhibitors

View page
US Patent:
20160207933, Jul 21, 2016
Filed:
Aug 25, 2015
Appl. No.:
14/835402
Inventors:
- Cambridge MA, US
Cassandra CELATKA - Hull MA, US
Seng CHENG - Natick MA, US
Mary A. CROMWELL - Groton MA, US
Andrew GOOD - Wallingford CT, US
Bradford HIRTH - Framingham MA, US
Katherine JANCSICS - Wilmington MA, US
John P. LEONARD - Manchester NH, US
Lingyun LI - Waltham MA, US
James LILLIE - Wellesley MA, US
Hanlan LIU - Lexington MA, US
Elina MAKINO - Winchester MA, US
John MARSHALL - Hopedale MA, US
Paul MASON - Natick MA, US
Markus METZ - Waltham MA, US
Fazeela MORSHED - Waltham MA, US
Thomas O'SHEA - Wellesley MA, US
Ronald SCHEULE - Hopkinton MA, US
Renato SKERLJ - West Newton MA, US
Bing WANG - Newton MA, US
Yibin XIANG - Dracut MA, US
Zhong ZHAO - Wayland MA, US
International Classification:
C07D 487/08
A61K 31/439
A61K 38/47
A61K 31/551
C07D 455/02
A61K 31/46
C07D 453/02
A61K 31/506
Abstract:
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.

Glucosylceramide Synthase Inhibitors

View page
US Patent:
20150210681, Jul 30, 2015
Filed:
Sep 10, 2013
Appl. No.:
14/427275
Inventors:
- Cambridge MA, US
Cassandra Celatka - Chesterfield MA, US
Seng H. Cheng - Wellesley MA, US
Bradford Hirth - Littleton MA, US
Andrew Good - Wallingford CT, US
Katherine Jancsics - Wilmington MA, US
John Marshall - Hopedale MA, US
Markus Metz - Waltham MA, US
Ronald K. Scheule - Hopkinton MA, US
Renato Skerlj - Newton MA, US
Yibin Xiang - Dracut MA, US
Zhong Zhao - Wayland MA, US
John Leonard - Bridgewater NJ, US
Thomas Natoli - Southborough MA, US
Elina Makino - Winchester MA, US
Herve Husson - Boston MA, US
Oxana Beskrovnaya - Southborough MA, US
Assignee:
GENZYME CORPORATION - Cambrdige MA
International Classification:
C07D 453/02
C07D 471/08
A61K 31/55
A61K 45/06
A61K 31/506
A61K 31/497
A61K 31/439
A61K 31/5377
A61K 31/496
A61K 31/551
Abstract:
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.

Glucosylceramide Synthase Inhibitors

View page
US Patent:
20140371460, Dec 18, 2014
Filed:
Aug 28, 2014
Appl. No.:
14/471958
Inventors:
- Cambridge MA, US
Cassandra CELATKA - Hull MA, US
Bradford HIRTH - Framingham MA, US
Markus METZ - Waltham MA, US
Zhong ZHAO - Wayland MA, US
Yibin XIANG - Dracut MA, US
Katherine JANCSICS - Wilmington MA, US
John MARSHALL - Hopedale MA, US
Seng CHENG - Natick MA, US
Ronald SCHEULE - Hopkinton MA, US
Andrew GOOD - Wallingford CT, US
International Classification:
C07D 453/02
US Classification:
546137
Abstract:
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.

Glucosylceramide Synthase Inhibitors

View page
US Patent:
20140255381, Sep 11, 2014
Filed:
Sep 18, 2013
Appl. No.:
14/030725
Inventors:
- Cambridge MA, US
Cassandra CELATKA - Hull MA, US
Bradford HIRTH - Framingham MA, US
Markus METZ - Waltham MA, US
Zhong ZHAO - Wayland MA, US
Yibin XIANG - Dracut MA, US
Katherine JANCSICS - Wilmington MA, US
John MARSHALL - Hopedale MA, US
Seng CHENG - Natick MA, US
Ronald SCHEULE - Hopkinton MA, US
Andrew GOOD - Wallingford CT, US
Assignee:
GENZYME CORPORATION - Cambridge MA
International Classification:
C07D 453/02
A61K 38/47
A61K 31/439
US Classification:
424 9461, 546137, 514305
Abstract:
The invention relates to inhibitors of glucosylceramide synthase (GCS) useful for the treatment metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, and for the treatment of cancer.
Control profile
Katherine C Jancsics from Wilmington, MA, age ~46 Get Report